Preserving Competition, FTC Requires Divestiture Before Allowing Allergans Acquisition of Inamed
Date
Botox marketer Allergan, Inc., and the Inamed Corporation will divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle Federal Trade Commission charges that Allergan’s...